Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
93%
Adverse Event
15%
Alteplase
10%
Amyotrophic Lateral Sclerosis
14%
Anticoagulant Agent
21%
Antithrombotic Therapy
6%
Atrial Fibrillation
15%
Bleeding
16%
Brain Hemorrhage
17%
Brain Ischemia
54%
Cause of Death
8%
Cerebrovascular Accident
64%
Clinical Trial
29%
Congestive Heart Failure
95%
Diseases
18%
Disorders of Mitochondrial Functions
17%
Gavestinel
9%
Glycine Receptor Antagonist
9%
Heart Failure with Reduced Ejection Fraction
25%
Mitochondrial DNA
13%
Myopathy
8%
Neuroprotection
9%
Phase II Trials
6%
Placebo
14%
Randomized Clinical Trial
6%
Randomized Controlled Trial
14%
Systolic Heart Failure
28%
Tenecteplase
14%
Thymidine Kinase
10%
Transient Ischemic Attack
9%
Ubidecarenone
11%
Warfarin
100%
Medicine and Dentistry
Acetylsalicylic Acid
26%
Amyotrophic Lateral Sclerosis
19%
Antithrombotic
14%
Apoplexy
35%
Atrial Fibrillation
21%
Bleeding
12%
Brain Ischemia
18%
Cardiovascular System
10%
Carotid Artery Stenosis
12%
CHA2DS2-VASc Score
5%
Clinical Trial
19%
Clinician
5%
Coenzyme Q10
11%
Congestive Heart Failure
21%
Diagnosis
23%
Dietary Supplement
5%
Diseases
19%
Disorders of Mitochondrial Functions
35%
Doppler Flowmetry
6%
Doppler Ultrasound
6%
Ejection Fraction
21%
Hazard Ratio
11%
Heart Failure with Reduced Ejection Fraction
19%
Infarction
22%
Ischemia
6%
Mitochondrial DNA
12%
Myopathy
8%
Odds Ratio
13%
Outpatient
6%
Phase II Trials
6%
Placebo
5%
Post-Hoc Analysis
5%
Prospective Study
10%
Rare Disease
7%
Rating Scale
11%
Side Effect
5%
Sinus Rhythm
12%
Stenosis
6%
Systolic Heart Failure
21%
Thrombus
6%
Thymidine Kinase
9%
Transcranial Doppler
9%
Transient Ischemic Attack
5%
Warfarin
29%
Nursing and Health Professions
Amyotrophic Lateral Sclerosis
9%
Anticoagulant Agent
6%
Anticoagulation
5%
Atrial Fibrillation
12%
Brain Ischemia
8%
Cerebrovascular Accident
24%
Confidence Interval
17%
Congestive Heart Failure
28%
Diagnosis
10%
Disorders of Mitochondrial Functions
9%
Heart Ejection Fraction
29%
Heart Failure with Reduced Ejection Fraction
11%
Heart Left Ventricle Ejection Fraction
8%
International Normalized Ratio
5%
New York Heart Association Class
7%
Odds Ratio
9%
Post Hoc Analysis
5%
Rare Disease
5%
Rating Scale
9%
Systolic Heart Failure
9%
Warfarin
38%
